Zilong Tan

Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Targeting PSMB2 suppresses glioblastoma progression and sensitizes tumors to temozolomide by modulating PTEN/PI3K/AKT pathway.

Targeting PSMB2 suppresses glioblastoma progression and sensitizes tumors to temozolomide by modulating PTEN/PI3K/AKT pathway.

Journal: Gene
Published: May 09, 2026

RBM43 promotes glioma aggressiveness and shapes the immune microenvironment through macrophage polarization.

RBM43 promotes glioma aggressiveness and shapes the immune microenvironment through macrophage polarization.

Journal: Discover oncology
Published: February 04, 2026

Advances in the Understanding and Mechanisms of Cabergoline-induced Valvulopathy in Prolactinoma Patients.

Advances in the Understanding and Mechanisms of Cabergoline-induced Valvulopathy in Prolactinoma Patients.

Journal: Mini reviews in medicinal chemistry
Published: July 20, 2025

PSMB2 plays an oncogenic role in glioma and correlates to the immune microenvironment.

PSMB2 plays an oncogenic role in glioma and correlates to the immune microenvironment.

Journal: Scientific reports
Published: December 07, 2023

Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma.

Decapping enzyme 2 is a novel immune-related biomarker that predicts poor prognosis in glioma.

Journal: Biotechnology & genetic engineering reviews
Published: May 16, 2023

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.

Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.

Journal: Frontiers in genetics
Published: September 25, 2022

Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.

Integrin subunit alpha V is a potent prognostic biomarker associated with immune infiltration in lower-grade glioma.

Journal: Frontiers in neurology
Published: June 08, 2022

High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas.

High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas.

Journal: Frontiers in genetics
Published: May 17, 2021

Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma.

Three-Dimensional Radiomics Features From Multi-Parameter MRI Combined With Clinical Characteristics Predict Postoperative Cerebral Edema Exacerbation in Patients With Meningioma.

Journal: Frontiers in oncology
Published: November 02, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026